Lanean...
Soluble fibrinogen-like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function
Soluble fibrinogen-like protein 2 (sFGL2), as a novel effector of regulatory T cells (Tregs), exhibits immune regulatory activity in several inflammatory diseases. Immune activation and persistent inflammation participate in the progression of ischemic heart failure (IHF). The present study aimed to...
Gorde:
| Argitaratua izan da: | Mol Med Rep |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8188637/ https://ncbi.nlm.nih.gov/pubmed/34109427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2021.12198 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|